Finance

Lists
603207:SHA
Shanghai Xiao Fang Pharmaceutical Co Ltd
CN¥22,93
-0,39%
(-0,090) 1D
15 Okt., 10:52:52 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603207...
Open
CN¥22,67
High
CN¥23,18
Low
CN¥22,52
Mkt. cap
3,83 mjd
Avg. vol.
4,35 m
Volume
784,14 k
P/E ratio
19,11
52-wk high
CN¥34,05
52-wk low
CN¥21,31
EPS
CN¥1,20
No. of employees
529
Open
CN¥22,67
High
CN¥23,18
Low
CN¥22,52
Mkt. cap
3,83 mjd
Avg. vol.
4,35 m
Volume
784,14 k
P/E ratio
19,11
52-wk high
CN¥34,05
52-wk low
CN¥21,31
EPS
CN¥1,20
No. of employees
529
News stories
From web sources and news partners
The Daily News | Texas' Oldest Newspaper
The Daily News | Texas' Oldest Newspaper
·
28 minute gelede
FILE PHOTO: SK Hynix at the Nasdaq market in New York
Yardeni QuickTakes
Yardeni QuickTakes
·
4 minute gelede
Continue To Proceed With Caution
The Globe and Mail
The Globe and Mail
·
45 minute gelede
U.S. Analyst Updates: October 14th, 2026
About Shanghai Xiao Fang Pharmaceutical Co Ltd
CEO-
Employees529
Founded12 Aug. 1993
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
127,43 m
128,06 m
145,69 m
136,24 m
Cost of goods sold
46,65 m
51,91 m
56,93 m
53,30 m
Cost of revenue
46,65 m
51,91 m
56,93 m
53,30 m
Research and development expenses
4,30 m
10,17 m
1,66 m
4,27 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
20,18 m
21,84 m
20,43 m
22,44 m
Operating expense
24,84 m
33,46 m
23,56 m
26,87 m
Total operating expenses
71,49 m
85,37 m
80,49 m
80,17 m
Operating income
55,94 m
42,69 m
65,20 m
56,06 m
Other non operating income
479,65 k
-506,54 k
-3,00 k
-5,29 k
EBT including unusual items
56,93 m
42,91 m
65,46 m
58,00 m
EBT excluding unusual items
57,14 m
42,26 m
65,40 m
58,16 m
Income tax expense
7,86 m
5,31 m
9,46 m
8,46 m
Effective tax rate
13,81%
12,38%
14,44%
14,58%
Other operating expenses
696,23 k
1,03 m
966,73 k
613,76 k
Net income
49,07 m
37,60 m
56,01 m
49,54 m
Net profit margin
38,51%
29,36%
38,44%
36,37%
Earnings per share
-
-
-
-
Interest and investment income
714,36 k
97,60 k
204,34 k
2,12 m
Interest expense
-1,30 k
-19,01 k
-4,80 k
-13,15 k
Net interest expenses
713,06 k
78,59 k
199,54 k
2,10 m
Depreciation and amortization charges
-
-
-
-
EBITDA
56,54 m
43,17 m
65,68 m
57,07 m
Gain or loss from assets sale
-
-110,62 k
-
5,64 k
AI content may include mistakes. Learn more
Google-programme